Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
about
Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsTargeted delivery of curcumin to tumors via PEG-derivatized FTS-based micellar system.Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphomaMechanisms of RAS/β-catenin interactions.Enhancing FTS (Salirasib) efficiency via combinatorial treatment.The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer.The third dimension: new developments in cell culture models for colorectal research.Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.Novel FTS-diamine/cinnamic acid hybrids inhibit tumor cell proliferation and migration and promote apoptosis via blocking Ras-related signaling in vitro.The impact of pyrvinium pamoate on colon cancer cell viability.Hybrid molecule from Farnesylthiosalicylic acid-diamine and phenylpropenoic acid as Ras-related signaling inhibitor with potent antitumor activities.Endometrial Carcinoma: Specific Targeted Pathways.Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancerβ-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
P2860
Q26991723-4DFA7FA6-BA33-4A43-A88C-04959479AA09Q28546685-63FD2217-8AFB-4EF0-91C8-96A8A60FC8ADQ33574102-72570463-F7C5-47F4-BA4A-079F7A7A827EQ36275798-CEA83241-1766-4F64-AEE1-6131FAB0A462Q37687313-CB425A97-3ED3-4933-8CCF-877EB12A10DAQ38088654-F93C4B5D-EC0F-4FB6-B47D-7D0CE5B9DDF5Q38367291-3007A436-E8FF-4B6E-8F7A-875E52C607ACQ38743421-5EA6D530-19B4-4447-A594-268885C347EBQ38773122-A2DB74AB-888A-41F6-9058-FE9DC794B895Q38891257-91D56C2B-67D2-4DD6-AAEF-65A50012D370Q38925248-FA8F53E7-0627-484E-9E0F-C68978A239F5Q38971955-09B175A6-1435-495C-B5A9-E1F51CEEF4C0Q38973702-645829D3-6C20-4FBC-914C-7BE5EAE53927Q39026766-75EF5D45-B597-43D6-A049-842BCD455646Q39140763-C2B33E71-261D-4866-A502-A2112D3CE186Q49547317-A67B1B76-BBA2-48DE-921A-7B130EB292B1Q51416911-049145F7-D2A5-423F-BBC5-6087EEF912DC
P2860
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@ast
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@en
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@nl
type
label
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@ast
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@en
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@nl
prefLabel
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@ast
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@en
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@nl
P2093
P2860
P1433
P1476
Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells
@en
P2093
Luca Mologni
Monica Ceccon
Stefania Brussolo
P2860
P304
P356
10.1371/JOURNAL.PONE.0051449
P407
P577
2012-01-01T00:00:00Z